Article

(2021) Fetal toxicity associated with statins: A systematic review and meta-analysis. Atherosclerosis. pp. 59-67. ISSN 0021-9150

(2021) Game of "crowning" season 8: RAS and reproductive hormones in COVID-19-can we end this viral series? Archives of Medical Science. pp. 275-284. ISSN 1734-1922

(2021) Harnessing polyphenol power by targeting eNOS for vascular diseases. Critical Reviews in Food Science and Nutrition. p. 26. ISSN 1040-8398

(2021) How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors. Prog Cardiovasc Dis. pp. 65-74. ISSN 0033-0620

(2021) Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases - A position paper from the International Lipid Expert Panel (ILEP). Prog Cardiovasc Dis. pp. 40-52. ISSN 0033-0620

(2021) Improved COVID-19 ICU admission and mortality outcomes following treatment with statins: a systematic review and meta-analysis. Archives of Medical Science. pp. 579-595. ISSN 1734-1922

(2021) New Trends in the Pharmacological Intervention of PPARs in Obesity: Role of Natural and Synthetic Compounds. Current Medicinal Chemistry. pp. 4004-4022. ISSN 0929-8673

(2021) Pre-Clinical Evaluation of the Nanoliposomal antiPCSK9 Vaccine in Healthy Non-Human Primates. Vaccines. p. 11.

(2021) Rationale for Effective Prophylaxis Against COVID-19 Through Simultaneous Blockade of Both Endosomal and Non-Endosomal SARS-CoV-2 Entry into Host Cell. Cts-Clinical and Translational Science. pp. 431-433. ISSN 1752-8054

(2021) Statin therapy in chronic viral hepatitis: a systematic review and meta-analysis of nine studies with 195,602 participants. Annals of Medicine. pp. 1227-1242. ISSN 0785-3890

(2021) Statin therapy in hepatitis: a systematic review and meta-analysis of 9 studies with 195,602 participants. European Heart Journal. p. 2949. ISSN 0195-668X

(2021) The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP). Clin Nutr. pp. 255-276. ISSN 0261-5614

(2021) A systematic review and meta-analysis on the effects of statins on pregnancy outcomes. Atherosclerosis. pp. 1-11. ISSN 0021-9150

(2020) Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic. Pharmacological Research. p. 4. ISSN 1043-6618

(2020) Epidemiology of facial fractures: incidence, prevalence and years lived with disability estimates from the Global Burden of Disease 2017 study. Injury Prevention. pp. 27-35. ISSN 1353-8047

(2020) Global trends of hand and wrist trauma: a systematic analysis of fracture and digit amputation using the Global Burden of Disease 2017 Study. Injury Prevention. pp. 115-124. ISSN 1353-8047

(2020) Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. pp. 709-733. ISSN 0140-6736

(2020) Glucose-6-phosphate dehydrogenase deficiency and SARS-CoV-2 mortality: Is there a link and what should we do? Clinical Biochemistry. pp. 31-33. ISSN 0009-9120

(2020) How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors. Prog Cardiovasc Dis. ISSN 0033-0620

(2020) Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID-19: Shoot the messenger! Journal of Cellular and Molecular Medicine. pp. 10267-10269. ISSN 1582-1838

(2020) Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2. Archives of Medical Science. pp. 519-521. ISSN 1734-1922

(2020) Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000-17. The Lancet Global Health. e1038-e1060. ISSN 2214109X (ISSN)

(2020) New trends in the pharmacological intervention of PPARs in obesity: Role of natural and synthetic compounds. Curr Med Chem. ISSN 0929-8673

(2020) Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy? Archives of Medical Research. pp. 733-735. ISSN 0188-4409

(2020) Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon? Biochimie. pp. 50-52. ISSN 0300-9084

(2020) The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterology & Hepatology. pp. 245-266.

(2019) Association of Serum PCSK9 Levels with Antibiotic Resistance and Severity of Disease in Patients with Bacterial Infections Admitted to Intensive Care Units. Journal of Clinical Medicine. p. 9.

(2019) Epidemiology of facial fractures: Incidence, prevalence and years lived with disability estimates from the Global Burden of Disease 2017 study. Injury Prevention. ISSN 13538047 (ISSN)

(2019) Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology. pp. 439-458. ISSN 1474-4422

(2019) Novel therapeutic strategies for stroke: The role of autophagy. Critical Reviews in Clinical Laboratory Sciences. pp. 182-199. ISSN 1040-8363

(2019) Plasma PCSK9 levels and atherosclerosis burden in the coronary arteries of patients undergoing coronary angiography. European Heart Journal. p. 472. ISSN 0195-668X